ROSENBLUM MARK J (Exec VP Finance, Interim CFO) purchased 40.0% of their position (2K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $1.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/20/2020ACC: 0001615219-20-000005
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+2K
Net shares
Net buyer
$1.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$0.95
Trade value
$1.90K
% of position
40.0%
2/19/2020
5K→7K
Total
Net shares
+2K
Net value
$1.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2020 | P · Purchase | +2K | $0.95 | $1.90K | 40.0% | 5K | 7K |
| Total | +2K | $1.90K | ||||||
Derivative Transactions0
No derivative transactions reported